generation of invasive breast cancer cell lines for in vivo imaging
TRANSCRIPT
Generation of invasive breast cancer cell lines for in vivo imaging Jae Beom Kim, Kenneth Wong, and Konnie Urban. Life Sciences & Technology, PerkinElmer Inc., Alameda, CA
Cell culture
Human breast cancer cell line MDA-MB-231 cells were transfected with luciferase 2 cDNA (MDA-MB-231-luc2, PerkinElmer). MDA-MB-231-luc2-tdTomato cells were generated by transfecting tdTomato
cDNA into MDA-MB-231-luc2 cells. Cells were grown in MEM media supplemented with 10% fetal
bovine serum (Hyclone) without antibiotics. Growth curves were generated by seeding 100,000 cells
in a T25 flask. At each time point, cells were trypsinized and counted using an automatic cell counter
(Nexcelom, Lawrence, MA). Total numbers of cells were plotted in a logarithmic scale. Secondary tumor cell lines were established using limited dilution. The luminescence and/or fluorescence
stability were monitored for 4 weeks.
Tumor implantation
All the procedures for animal care and tumor cell implantation followed the approved animal protocols and guidelines of the Institutional Animal Care and Use Committee (IACUC). Prior to implantation, all
tumor cells were tested for the presence of mycoplasma and mouse pathogens. Female athymic
nude mice (Charles River) were anesthetized with isoflurane and two million MDA-MB-231-luc2 or
MDA-MB-231-luc2-tdTomato cells were orthotopically implanted into mammary fat pads of athymic
nude mice.
In vitro and in vivo fluorescent and bioluminescent imaging
For in vivo imaging, mice were anesthetized with isoflurane. Mice were subjected to in vivo tdTomato
imaging using the IVIS Spectrum (PerkinElmer). Multispectral images were spectrally unmixed using
Living Image software (PerkinElmer). For MDA-MB-231-luc2 tumor imaging in vivo, mice were injected with D-luciferin. Bioluminescent images were taken using IVIS Spectrum. Once tumor
metastasized into lymph nodes, secondary tumor was excised from the animals and bioluminescent
images were taken using IVIS Spectrum.
Histology, Immunofluorescence and tissue image processing Tissues were harvested at post-implantation day 7 and embedded in paraffin. Sections were cut at 7
mm thickness. For MDA-MB-231-luc2-LN cells, PathScan Signaling Nodes Mutiplex IF Kit (Cell
Signaling Technology) was used. Staining procedures followed the manufacture’s recommendation.
Once the staining was done, cells were mounted using DAPI containing mounting media. Multi-
spectral images were taken with an epifluorescence microscope (Nikon E400) equipped with Nuance camera (PerkinElmer).
Abstract 1
Tumor metastases with MDA-MB-231-luc2 and MDA-MB-luc2-tdTomato cells and establishment of new cell lines
In vivo monitoring of tumor growth
Summary
MDA-MB-231-luc2-LN cells were implanted into the mammary fat pads of athymic nude mice (n=12). Tumor growth was
monitored using bioluminescent imaging. Two animals showed no palpable tumor. Six representative animals are shown at day 24 and 32. For imaging, primary tumors were masked to detect metastases in the lymph nodes. Quantitation of bioluminescence
was performed using Living Image software. MDA-MB-231-luc2-tdTomato-LN cells showed similar pattern of metastases (Data not shown).
1. Tumor growth was monitored using MDA-MB-231-luc2 and MDA-MB-
luc2-tdTomato cells in vivo using bioluminescence and/or
fluorescence imaging in real time.
2. Secondary tumors were isolated from metastasized lymph nodes
and new cell lines were established.
3. Newly established cell lines showed different growth patterns from those of parental cell lines.
4. MDA-MB-231-luc2-LN and MDA-MB-231-luc2-tdTomato-LN cell lines
metastasize faster than parental cells.
4 Biomarkers in MDA-MB-231-luc2-LN cells
IVIS Spectrum and Nuance camera are shown. Whole animal in vivo imaging was done using an IVIS Spectrum. Multispectral
fluorescence microscopic images were taken using a Nuance camera. Spectral unmixing for in vivo and in vitro fluorescence imaging was done using Living Image and Nuance software respectively.
5 Instruments
IVIS and Nuance camera
Autofluorescence (removed from quantitation)
Spectral Unmixing
Acquisition
RGB
Representatio
n of Spectral
Cube
Label A
Label B
Label C
Label D
RGB
Spectra of labels
Once unmixed, labels can be measured accurately.
Materials & Methods
2
3 Tumor metastases with MDA-MB-231-luc2-LN cells
Large
Very Large
Very Large
MDA-MB-231-luc2 and MDA-MB-231-luc2-tdTomato cells were implanted into the mammary fat pads of athymic nude mice.
Tumor growth was monitored using bioluminescent imaging. Tumor volumes were measured using a caliper. Bioluminescent signals were quantitated using Living Image software. Representative mice were shown. (A) Mouse implanted with MDA-
MB-231-luc2 cells. (B) Mouse implanted with MDA-MB-231-luc2-tdTomato cells. Graphs next to the animals images are quantitation for tumor volumes, bioluminescent signals, and fluorescent signals.
MDA-MB-231-luc2 and MDA-MB-231-luc2-tdTomato cells were implanted into the mammary fat pads of athymic nude mice
and tumor metastases were monitored using bioluminescent imaging. Representative mice are shown. Ex vivo images of excised lymph nodes and growth curves are shown. Top Row: MDA-MB-231-luc2 cells. Bottom row: MDA-MB-231-luc2-
tdTomato cells.
0
200
400
600
800
1,000
0 30 60 90 120 150
Tu
mo
r V
olu
me
(mm
^3
)
Experimental Day
M #3 - Excision Day 126
Day 102 Day 107 Day 115 Day 126
Day 73 Day 93 Day 101 Day 106
MD
A-M
B-2
31-l
uc2
M
DA
-MB
-231
-lu
c2-t
dTo
mat
o
0
500
1,000
1,500
2,000
2,500
3,000
0 30 60 90 120
Tu
mo
r V
olu
me
(mm
^3
)
Experimental Day
#M6 - Excision Day 108
1.0E+04
1.0E+05
1.0E+06
1.0E+07
1.0E+08
1.0E+09
1.0E+10
1.0E+11
1.0E+12
0 30 60 90 120 150
Tota
l F
lux
(p
ho
ton
s/se
c)
Experimental Day
M#6 - Excision Day 108
M #6
Non-Palpable Tumor (N=3)
Background
0123456789
10
0 30 60 90 120 150
To
tal
Ra
dia
nt
Eff
icie
ncy
( X
10
^8
)
Experimental Day
M #6 - Excision Day 108
M #6
Non-Palpable Tumor (N=3)
Background
Cultured MDA-MB-231-luc2-LN cells were stained with
PathScan signaling nodes multiplex immunofluorescence kit (Cell Signaling Technology).
Cells were counter stained with DAPI and fluorescent
images were taken using Nuance camera. Each signal was spectrally unmixed using Nuance software. (A)
Image before unmixing, (B) Spectrally unmixed image, (C) Unmixed DAPI image, (D) Unmixed Phospho-
Erk1/2 image (Alexa Flour 488), (E) Unmixed Phospho
Akt (Alexa Flour 555), (F) Unmixed Phospho-S6 ribosomal protein (Alexa Flour 647).
A B
C D
E F
DAPI Phospho-Erk1/2
Phospho Akt Phospho-S6
Before Unmixing After Unmixing
A
B
MD
A-M
B-2
31-
luc2
M
DA
-MB
-231
-lu
c2
-td
Tom
ato
Day 24
Day 32
Mouse #2 Mouse #5 Mouse #6 Mouse #8 Mouse #9
Day 107 Day 115 Day 126 Ex vivo
0.00E+00
1.00E+05
2.00E+05
3.00E+05
4.00E+05
5.00E+05
6.00E+05
7.00E+05
0 24 48 72 96
MDA-MB-231-luc2-tdTomato vs. MDA-MB-luc2-tdTomato-LN
MDA-MB-231-luc2-tdTomato MDA-MB-231-luc2-tdTomato-LN
Bioluminescence Tumor volume
Bioluminescence Tumor volume Fluorescence
Growth Curve
MD
A-M
B-2
31-l
uc2-L
N
Whole animal non-invasive imaging contributes significantly to understand tumor behavior. It
also plays a critical role in drug discovery and development. Optical imaging is convenient
because it does not require radioactive materials for imaging. Especially in preclinical
applications, optical imaging can be a very useful tool because genetic modification is
feasible. The most popular optical imaging is using bioluminescence. We introduced various
cancer cell lines that express firefly luciferase. These cells have stable expression of light
emission for prolonged cell culture situation. This enables researchers to implant the cells into
animals and monitor tumor development and metastasis. In addition, these tumor cells can be
detected using fluorescent agents that target tumor cells. As a consequence, one can co-
register both bioluminescent and fluorescent images. Cells also can be labeled with both
bioluminescent and fluorescent markers such as luciferases and fluorescent proteins.
Although there are many different types of cell lines available for different tumor types,
studying metastasis can be challenging. That is mainly because most cell lines show delayed
metastasis when implanted in the animal. To expedite the metastasis, intravenous injection or
intracardiac injection is performed to generate secondary tumors in the animal. However,
these methods do not represent true metastasis from originated organs. One of the most
popular breast cancer cell line is MDA-MB-231. When these cells are implanted into
mammary fat pads of female nude mice, it typically takes more than 90 days to detect
metastasis in the secondary sites. Therefore, to study the tumor behavior or to examine the
drug efficacy, one has to wait for a long time to see metastasis with MDA-MB-231 cell line.
Here, we generated tumor cell lines that were derived from MDA-MB-231 originated cells. We
took MDA-MB-231 cells that were labeled with either luciferase (MDA-MB-231-luc2) or
luciferase & tdTomato fluorescent protein (MDA-MB-231-luc2-tdTomato). These cells were
implanted into mammary fat pads of nude mice and secondary tumors were isolated from
lymph nodes. Tissues were dissociated to single cells and clonal cell lines were established
(MDA-MB-231-luc2-LN and MDA-MB-231-luc2-tdTomato-LN). The growth patterns of these
cells were compared to their corresponding parental cells. To find out the metastasis patterns
of these cells, we implanted new cell lines orthotopically into nude mice. Our results showed
that these cell lines showed faster metastasis than parental cell lines. Moreover, we examined
biomarker expression patterns with multiplexing multispectral microscopy. These cells can be
used to study tumor metastasis and drug discovery using non-invasive in vivo imaging.